Expression of YTHDF2 and UBXN1 in Gliomas and Their Prognostic Value
10.3969/j.issn.1671-7414.2024.06.022
- VernacularTitle:脑胶质瘤组织中YTHDF2,UBXN1的表达及其对预后的评估价值
- Author:
Mingxu SHI
1
;
Jing GONG
;
Xiaowei LI
Author Information
1. 青岛市胶州中心医院神经外科,青岛 266300
- Keywords:
glioma;
YTH domain N6-methyladenine RNA binding protein 2;
UBX domain protein 1
- From:
Journal of Modern Laboratory Medicine
2024;39(6):130-134,210
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study aims to investigate the expression of YTH domain N6-methyladenine RNA binding protein 2(YTHDF2)and UBX domain protein 1(UBXN1)in glioma tissue and their prognostic value.Methods A total of 92 glioma cases that underwent surgical treatment in Qingdao Jiaozhou Central Hospital from February 2017 to February 2018 were included.Immunohistochemistry was used to detect YTHDF2 and UBXN1 expression.Spearman rank correlation analysis was conducted.Kaplan-Meier survival curves were plotted to analyze the association between YTHDF2,UBXN1 expression and prognosis in glioma patients.COX analysis was used to determine the prognostic factors affecting glioma patients.Results Compared with adjacent tissues,the positivity rate of YTHDF2(65.22％vs 15.22％)was significantly higher in gliomas,while the positivity rate of UBXN1(26.09％vs 73.91％)was lower,and differences were statistically significant(x2=47.831,42.087,all P<0.05).Spearman rank correlation analysis,showed a negative correlation between YTHDF2 and UBXN1 expression in gliomas(r=-0.712,P<0.05).Compared with tumors diameter<3cm and WHO grades Ⅰ to Ⅱ,YTHDF2(75.47％vs 51.28％,65.22％vs 50.00％)had a higher positivity rate in glioma tissues with tumor diameter≥3cm and WHO grade Ⅲ,while UBXN1(15.09％vs 41.03％,11.11％vs 47.37％)had a lower positivity rate,and differences were statistically significant(x2=5.795,6.609;7.835,15.207,all P<0.05).The five-year overall survival rate of YTHDF2 positive group was lower than that of negative group[28.33％(17/60)vs 62.50％(20/32)],while the five-year overall survival rate of UBXN1 positive group was higher than that of negative group[66.67％(16/24)vs 30.88％(21/68)],and the differences were statistically significant(Log-Rank x2=12.870,7.665,all P<0.05).YTHDF2 positive(HR=2.427,95％CI:1.426～4.569),UBXN1 negative(HR=1.740,95％CI:1.121～2.568),WHO grade Ⅲ(HR=2.671,95％CI:1.160～6.012)and tumor diameter≥3cm(HR=1.628,95％CI:1.017～2.592)were risk factors for poor survival prognosis in glioma patients.Conclusion YTHDF2 increased and UBXN1 decreased in glioma tissues,both of which are related to WHO grading and tumor diameter,and they are independent factors for evaluating the prognosis of glioma patients.
